BridgeBio Oncology Therapeutics Inc Com (BBOT) Income Statement (2024 - 2026)
Income Statement report data from Mar 31, 2024 to Mar 31, 2026 for BridgeBio Oncology Therapeutics Inc Com (BBOT).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Jun 30, 2024 | Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|
Operating Expenses | ||||||||
Research And Development | 40M (-39.25%) | 66M (+86.90%) | 35M | - | 21M (-62.62%) | 55M | - | - |
Selling General And Administrative | 6.38M (-7.13%) | 6.87M (-51.38%) | 14M (+1161.61%) | 1.12M (-55.20%) | 2.50M | -1.41M | 150K (+114.29%) | 70K |
Operating Expenses | 46M (-36.20%) | 72M (+47.17%) | 49M (+4291.07%) | 1.12M (-95.16%) | 23M (-62.05%) | 61M (+40553.33%) | 150K (+114.29%) | 70K |
Depreciation And Amortization | 70K (-69.57%) | 230K | - | - | 50K (-76.19%) | 210K | - | - |
Operating Income | ||||||||
Operating Income | -46.18M (-36.20%) | -72.38M (+47.17%) | -49.18M (+4291.07%) | -1.12M (-95.16%) | -23.14M | 19M | -150.00K (+114.29%) | -70.00K |
Ebit | -46.18M (-36.20%) | -72.38M (+47.17%) | -49.18M (+4291.07%) | -1.12M (-95.16%) | -23.14M | 19M | -150.00K (+114.29%) | -70.00K |
EBITDA | -46.10M (-6.41%) | -49.26M (+10.05%) | -44.76M (+57.44%) | -28.43M (+23.18%) | -23.08M | 54M | -21.82M (+41.32%) | -15.44M |
Other Income / Expenses | ||||||||
Interest Income | - | -4.06M | - | 2.07M (+4.02%) | 1.99M (-11.56%) | 2.25M (-7.79%) | 2.44M (+101.65%) | 1.21M |
Net Interest Income | - | -4.06M | - | 2.07M (+4.02%) | 1.99M (-11.56%) | 2.25M (-7.79%) | 2.44M (+101.65%) | 1.21M |
Other Non Operating Income | -90.00K (+125.00%) | -40.00K (+33.33%) | -30.00K | 2.04M | - | - | 2.36M (+101.71%) | 1.17M |
Net Income | ||||||||
Net Income From Continuing Operations | -42.11M (+8.53%) | -38.80M (-13.32%) | -44.76M (+57.44%) | -28.43M (+28.93%) | -22.05M | 62M | -21.82M (+41.32%) | -15.44M |
Net Income | -42.11M (+8.53%) | -38.80M (-13.32%) | -44.76M (+57.44%) | -28.43M (+28.93%) | -22.05M | 62M | -21.82M (+41.32%) | -15.44M |
Comprehensive Income Net Of Tax | -43.10M (-67.93%) | -134.38M (+200.16%) | -44.77M | - | -22.21M (-69.96%) | -73.93M | - | - |